Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-11-10

Clinical Trial Update: Intermittent Fasting for the Treatment of Type 2 Diabetes Mellitus [NA]

View source ↗

Summary

A clinical trial evaluating intermittent fasting as a treatment for Type 2 diabetes mellitus has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: University of Kansas Medical Center | Conditions: Type 2 Diabetes | NA | Status: COMPLETED